[{"NetIncomeLoss_2_Q2_USD":-14392000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":13357000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":18458000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":10577000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":17549118.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":16986485.0,"LiabilitiesNoncurrent_0_Q2_USD":61258000.0,"RestrictedCashCurrent_0_Q2_USD":1361000.0,"InterestPaidNet_2_Q2_USD":513000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":161000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-9349000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":70394000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":2495000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":164000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":1522000.0,"AssetsCurrent_0_Q2_USD":180377000.0,"LongTermDebtCurrent_0_Q2_USD":128000.0,"IncreaseDecreaseInAccountsAndNotesReceivable_2_Q2_USD":-1609000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":7675000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":3532000.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":5000000.0,"SellingAndMarketingExpense_2_Q2_USD":13184000.0,"SellingAndMarketingExpense_1_Q2_USD":5620000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":467009.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":593000.0,"CommonStockSharesIssued_0_Q2_shares":19544008.0,"Assets_0_Q2_USD":328491000.0,"ShareBasedCompensation_2_Q2_USD":3453000.0,"RepaymentsOfSecuredDebt_2_Q2_USD":61000.0,"ShareBasedCompensation_1_Q2_USD":2495000.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":0.0,"OperatingLeaseLiability_0_Q2_USD":120000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":2146000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":881000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":30.97,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":2691000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":17000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-129000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-190000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-121000.0,"AccountsReceivableNetCurrent_0_Q2_USD":14897000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":5000.0,"NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_Q2_USD":-14707000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":3285000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":66427000.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2_Q2_USD":0.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1_Q2_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":910000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":910000.0,"IncomeLossFromContinuingOperations_2_Q2_USD":-14392000.0,"IncomeLossFromContinuingOperations_1_Q2_USD":-9447000.0,"IncreaseDecreaseInInventories_2_Q2_USD":9599000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-14392000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-9447000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-14228000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-7925000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-746000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":113054000.0,"Liabilities_0_Q2_USD":86029000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":50000.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":404.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":123000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":70207000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":164000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":1522000.0,"CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2_Q2_USD":0.0,"Goodwill_0_Q2_USD":68420000.0,"InterestIncomeExpenseNet_2_Q2_USD":-1778000.0,"InterestIncomeExpenseNet_1_Q2_USD":-1399000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-14707000.0,"CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_0_Q2_USD":114415000.0,"LiabilitiesCurrent_0_Q2_USD":24771000.0,"AccountsPayableCurrent_0_Q2_USD":6003000.0,"NonoperatingIncomeExpense_2_Q2_USD":-2878000.0,"NonoperatingIncomeExpense_1_Q2_USD":-2430000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":114415000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1534000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1281000.0,"LongTermDebtNoncurrent_0_Q2_USD":21017000.0,"GrossProfit_2_Q2_USD":22274000.0,"GrossProfit_1_Q2_USD":10061000.0,"AdditionalPaidInCapital_0_Q2_USD":385510000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":0.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":30.97,"NotesAndLoansReceivableNetCurrent_0_Q2_USD":656000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":41370.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":42206000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"LongTermNotesAndLoans_0_Q2_USD":21017000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":28100000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":24131000.0,"NetIncomeLoss_1_Q2_USD":-9447000.0,"CommonStockSharesOutstanding_0_Q2_shares":19544008.0,"StockIssuedDuringPeriodValueAcquisitions_1_Q2_USD":37638000.0,"CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_2_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-143214000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0003,"NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_Q2_USD":-9349000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-66000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":50000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":29949000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":13593000.0,"OperatingIncomeLoss_2_Q2_USD":-11514000.0,"OperatingIncomeLoss_1_Q2_USD":-7017000.0,"InventoryNet_0_Q2_USD":48875000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":44897000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":30.97,"LiabilitiesAndStockholdersEquity_0_Q2_USD":328491000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4501000.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q2_USD":0.0,"ImpairmentOfIntangibleAssetsFinitelived_2_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_1_Q2_USD":0.0,"OperatingExpenses_2_Q2_USD":33788000.0,"OperatingExpenses_1_Q2_USD":17078000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.85,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.54,"OtherLiabilitiesNoncurrent_0_Q2_USD":120000.0,"OtherLiabilitiesCurrent_0_Q2_USD":2654000.0,"StockholdersEquity_0_Q2_USD":242462000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":5160000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":185000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":29258.0,"DebtLongtermAndShorttermCombinedAmount_0_Q2_USD":21145000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":42388000.0,"BusinessCombinationAcquisitionRelatedCosts_2_Q2_USD":737000.0,"Ticker":"KIDS","CIK":"1425450","name":"ORTHOPEDIATRICS CORP","OfficialName":"OrthoPediatrics Corp. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1000731682.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]